24/7 Patient Assistance: 760-405-8205

Larry Schlabach, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information
  • Education & Training


    Wright State University Boonshoft

    Medical School


    Erlanger Medical Center



    University of Alabama Medical Center


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Publications & Memberships

    Dr. Larry Schlabach has contributed to 3 publications.

    Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer.

    Cardin, D. B.,Goff, L.,Li, C. I.,Shyr, Y.,Winkler, C.,Devore, R.,Schlabach, L.,Holloway, M.,McClanahan, P.,Meyer, K.,Grigorieva, J.,Berlin, J.,Chan, E.; Cancer Med. 2014 Feb 28.

    See more >>

    A phase II study of concurrent chemoradiotherapy with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and ca...

    Hughes RS, Sandler AB, Jain AK, Dowlati A, Schwartzberg LS, Dobbs T, Schlabach L, Wu J, Muldowney NJ, Choy H; J. Clin. Oncol.. 2008-05-20.

    See more >>

    57 citations Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer.

    Heymach, J. V., Johnson, D. H., Khuri, F. R., Safran, H., Schlabach, L. L., Yunus, F., DeVore, R. F., De Porre, P. M., Richards, H. M., Jia, X., Zhang, S., Johnson, B. E.; Ann Oncol. 2004 Aug.

    See more >>


    American College of Physicians